{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T23:51:10Z","timestamp":1659052270355},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1992,11,1]],"date-time":"1992-11-01T00:00:00Z","timestamp":720576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gen Intern Med"],"published-print":{"date-parts":[[1992,11]]},"DOI":"10.1007\/bf02599196","type":"journal-article","created":{"date-parts":[[2007,4,3]],"date-time":"2007-04-03T05:55:29Z","timestamp":1175579729000},"page":"589-594","source":"Crossref","is-referenced-by-count":7,"title":["Preventive medicine for HIV-infected patients"],"prefix":"10.1007","volume":"7","author":[{"given":"David N.","family":"Rose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clyde B.","family":"Schechter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry S.","family":"Sacks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"suppl","key":"BF02599196_CR1","first-page":"1S","volume":"38","author":"Centers for Disease Control","year":"1989","unstructured":"Centers for Disease Control. A strategic plan for the elimination of tuberculosis in the United States. MMWR. 1989;38(suppl):1S-25S.","journal-title":"MMWR"},{"key":"BF02599196_CR2","first-page":"236","volume":"38","author":"Centers for Disease Control","year":"1989","unstructured":"Centers for Disease Control. Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). MMWR. 1989;38:236\u20138, 243\u201350.","journal-title":"MMWR"},{"key":"BF02599196_CR3","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1164\/ajrccm\/140.6.1788","volume":"140","author":"JF Murray","year":"1989","unstructured":"Murray JF. The white plague: down and out, or up and coming? J. Burns Amberson lecture. Am Rev Respir Dis. 1989;140:1788\u201395.","journal-title":"J. Burns Amberson lecture. Am Rev Respir Dis"},{"key":"BF02599196_CR4","first-page":"153","volume":"39","author":"Centers for Disease Control","year":"1990","unstructured":"Centers for Disease Control. Update: tuberculosis elimination\u2014United States. MMWR. 1990;39:153\u201369.","journal-title":"MMWR"},{"key":"BF02599196_CR5","first-page":"9","volume":"39","author":"Centers for Disease Control","year":"1990","unstructured":"Centers for Disease Control. The use of preventive therapy for tuberculous infection in the United States; recommendations of the Advisory Committee for the Elimination of Tuberculosis. MMWR. 1990;39:9\u201312.","journal-title":"MMWR"},{"key":"BF02599196_CR6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0041-3879(91)90018-N","volume":"72","author":"GH Bothamley","year":"1991","unstructured":"Bothamley GH, Grange JM. The Koch phenomenon and delayed hypersensitivity: 1891\u20131991. Tubercle. 1991;72:7\u201311.","journal-title":"Tubercle"},{"key":"BF02599196_CR7","first-page":"27","volume":"40","author":"Centers for Disease Control","year":"1991","unstructured":"Centers for Disease Control. Purified protein derivative (PPD) \u2014 tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR. 1991;40:27\u201333.","journal-title":"MMWR"},{"key":"BF02599196_CR8","unstructured":"Blatt SP, Donovan D, Freeman T, et al. Cutaneous delayed-type hypersensitivity (DTH) skin-testing in HIV-infected patients: implications for diagnosis and chemoprophylaxis of tuberculosis [abstract]. Florence, Italy: VII International Conference on AIDS, June 16\u201321, 1991; MB2292."},{"key":"BF02599196_CR9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00002030-199102000-00005","volume":"5","author":"JMG Taylor","year":"1991","unstructured":"Taylor JMG, Tan S-J, Detels R, Giorgi JV. Applications of a computer simulation model of the natural history of CD4 T-cell number in HIV-infected individuals. AIDS. 1991;5:159\u201367.","journal-title":"AIDS"},{"key":"BF02599196_CR10","doi-asserted-by":"crossref","DOI":"10.1002\/9780470316511","volume-title":"Simulation and the Monte Carlo method","author":"RY Rubenstein","year":"1981","unstructured":"Rubenstein RY. Simulation and the Monte Carlo method. New York: John Wiley & Sons, 1981."},{"key":"BF02599196_CR11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0140-6736(91)90414-K","volume":"338","author":"NMH Graham","year":"1991","unstructured":"Graham NMH, Zeger SL, Park LP, et al. Effect of zidovudine andPneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. Lancet. 1991;338:265\u20139.","journal-title":"Lancet"},{"key":"BF02599196_CR12","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJM199105163242006","volume":"324","author":"RD Moore","year":"1991","unstructured":"Moore RD, Hidalgo J, Sugland BW, Chaisson RE. Zidovudine and the natural history of the acquired immunodeficiency syndrome. N Engl J Med. 1991;324:1412\u20136.","journal-title":"N Engl J Med"},{"key":"BF02599196_CR13","unstructured":"National Center for Health Statistics. Vital Statistics of the United States, 1985, Vol. II, Mortality, Part A. DHHS Pub. No. (PHS) 88-1101. Public Health Service. Washington, DC: U.S. Government Printing Office, 1988."},{"key":"BF02599196_CR14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/0272989X8300300403","volume":"3","author":"JR Beck","year":"1983","unstructured":"Beck JR, Pauker SG. The Markov process in medical prognosis. Med Decis Making. 1983;3:419\u201358.","journal-title":"Med Decis Making"},{"key":"BF02599196_CR15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM198903023200901","volume":"320","author":"PA Selwyn","year":"1989","unstructured":"Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among injection drug users with human immunodeficiency virus infection. N Engl J Med. 1989;320:545\u201350.","journal-title":"N Engl J Med"},{"key":"BF02599196_CR16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1164\/ajrccm\/137.1.2","volume":"137","author":"DE Snider Jr","year":"1988","unstructured":"Snider DE Jr. Decision analysis for isoniazid preventive therapy: take it or leave it? Am Rev Respir Dis. 1988;137:2\u20134.","journal-title":"Am Rev Respir Dis"},{"key":"BF02599196_CR17","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1001\/archinte.1990.00390230071009","volume":"150","author":"GL Colice","year":"1990","unstructured":"Colice GL. Decision analysis, public health policy, and isoniazid chemoprophylaxis for young adult tuberculin skin reactors. Arch Intern Med. 1990;150:2517\u201322.","journal-title":"Arch Intern Med"},{"key":"BF02599196_CR18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJM199101313240503","volume":"324","author":"PM Small","year":"1991","unstructured":"Small PM, Schecter FG, Goodman PC, Sande MA, Chaisson RE, Hopewell PC. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med. 1991;324:289\u201394.","journal-title":"N Engl J Med"},{"key":"BF02599196_CR19","first-page":"28","volume":"17","author":"SH Ferebee","year":"1970","unstructured":"Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis: a general review. Adv Tuberc Res. 1970;17:28\u2013106.","journal-title":"Adv Tuberc Res"},{"key":"BF02599196_CR20","first-page":"555","volume":"60","author":"International Union against Tuberculosis Committee on Prophylaxis","year":"1982","unstructured":"International Union against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull WHO. 1982;60:555\u201364.","journal-title":"Bull WHO"},{"key":"BF02599196_CR21","first-page":"991","volume":"117","author":"DE Kopanoff","year":"1978","unstructured":"Kopanoff DE, Snider DE Jr, Caras GJ. Isoniazid-related hepatitis. Am Rev Respir Dis. 1978;117:991\u20131001.","journal-title":"Am Rev Respir Dis"},{"key":"BF02599196_CR22","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.1986.03380190079029","volume":"256","author":"DN Rose","year":"1986","unstructured":"Rose DN, Schechter CB, Silver AL: The age threshold for isoniazid chemoprophylaxis. JAMA. 1986;256:2709\u201313.","journal-title":"JAMA"},{"key":"BF02599196_CR23","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1001\/jama.1991.03460220075035","volume":"265","author":"TJ Jordan","year":"1991","unstructured":"Jordan TJ, Lewitt EM, Montgomery RL, Reichman LB. Isoniazid as preventive therapy in HIV-infected intravenous drug abusers: a decision analysis. JAMA. 1991;265:2987\u201391.","journal-title":"JAMA"},{"key":"BF02599196_CR24","unstructured":"Di Perri G, Micciolo R, Vento S, Cruciani M, Concia E, Bassetti D. CD4 count as predictor of reactivation of tuberculosis in HIV infection [abstract]. Florence, Italy: VII International Conference on AIDS, June 16\u201321, 1991;WB2359."},{"key":"BF02599196_CR25","first-page":"21","volume":"63","author":"G Slutkin","year":"1988","unstructured":"Slutkin G, Leowski J, Mann J. The effects of AIDS epidemic on the tuberculosis problem and tuberculosis programmes. Bull Int Union Tuberc Lung Dis. 1988;63:21\u20134.","journal-title":"Bull Int Union Tuberc Lung Dis"},{"key":"BF02599196_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0041-3879(91)90017-M","volume":"72","author":"A Kochi","year":"1991","unstructured":"Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle. 1991;72:1\u20136.","journal-title":"Tubercle"},{"key":"BF02599196_CR27","unstructured":"Dupon M, Ragnaud JM, et le Groupe des Infectiologues du Sud de la France. A retrospective cohort study of 123 HIV infected tuberculosis patients\u2014France, 1985\u20131989 [abstract]. Florence, Italy: VII International Conference on AIDS, June 16\u201321, 1991; WB2343."},{"key":"BF02599196_CR28","unstructured":"Zamora L, Gatell JM, Mallolas J, Guelar A, Miro JM, Soriano E. Treatment of tuberculosis in HIV-infected patients [abstract]. San Francisco, CA: VI International Conference on AIDS, June 20\u201324, 1990; ThB508."},{"key":"BF02599196_CR29","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1164\/ajrccm\/136.3.570","volume":"136","author":"RE Chaisson","year":"1987","unstructured":"Chaisson RE, Schecter GF, Theuer CP, Rutherford GW, Echenberg DF, Hopewell PC. Tuberculosis in patients with the acquired immunodeficiency syndrome; clinical features, response to therapy, and survival. Am Rev Respir Dis. 1987;136:570\u20134.","journal-title":"Am Rev Respir Dis"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02599196.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02599196\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02599196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T14:24:07Z","timestamp":1558189447000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02599196"}},"subtitle":["An analysis of isoniazid prophylaxis for tuberculin reactors and for anergic patients"],"short-title":[],"issued":{"date-parts":[[1992,11]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1992,11]]}},"alternative-id":["BF02599196"],"URL":"https:\/\/doi.org\/10.1007\/bf02599196","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,11]]}}}